Cross Country Healthcare Files Reg FD Disclosure on Feb 1, 2024

TL;DR

**CCRN just dropped a Reg FD 8-K, signaling important news is out for everyone.**

AI Summary

Cross Country Healthcare, Inc. filed an 8-K on February 1, 2024, under Regulation FD Disclosure. This filing indicates that the company is making a public disclosure of material non-public information, likely to ensure fair and broad dissemination to all investors simultaneously. For stockholders, this means the company is proactively sharing important news, which could impact their investment decisions, rather than allowing information to leak or be selectively disclosed.

Why It Matters

This filing ensures all investors receive material information at the same time, preventing unfair advantages and promoting transparency in the market for CCRN stock.

Risk Assessment

Risk Level: low — A Regulation FD disclosure itself is a procedural filing to ensure fair information dissemination, not an inherently risky event.

Analyst Insight

A smart investor would look for a subsequent press release or investor presentation from Cross Country Healthcare, Inc. that explains the specific material information being disclosed under Regulation FD, as this 8-K only signals that such information has been or will be released.

Key Players & Entities

• Cross Country Healthcare, Inc. (company) — the registrant filing the 8-K
• February 1, 2024 (date) — date of earliest event reported and filing date
• Nasdaq Stock Market LLC (company) — exchange where CCRN common stock is registered
• $0.0001 (dollar_amount) — par value per share of common stock

FAQ

From the Filing

0001628280-24-002913.txt : 20240201 0001628280-24-002913.hdr.sgml : 20240201 20240201162317 ACCESSION NUMBER: 0001628280-24-002913 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240201 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20240201 DATE AS OF CHANGE: 20240201 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CROSS COUNTRY HEALTHCARE INC CENTRAL INDEX KEY: 0001141103 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HELP SUPPLY SERVICES [7363] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 134066229 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-33169 FILM NUMBER: 24587261 BUSINESS ADDRESS: STREET 1: 6551 PARK OF COMMERCE BOULEVARD, N.W. CITY: BOCA RATON STATE: FL ZIP: 33487 BUSINESS PHONE: 8003472264 MAIL ADDRESS: STREET 1: 6551 PARK OF COMMERCE BOULEVARD, N.W. CITY: BOCA RATON STATE: FL ZIP: 33487 FORMER COMPANY: FORMER CONFORMED NAME: CROSS COUNTRY INC DATE OF NAME CHANGE: 20010521 8-K 1 ccrn-20240201.htm 8-K ccrn-20240201 0001141103 FALSE 0001141103 2024-02-01 2024-02-01 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.  20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 1, 2024 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 6551 Park of Commerce Boulevard, N.W. , Boca Raton , FL 33487 (Address of Principal Executive Office) (Zip Code) ( 561 ) 998-2232 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Securities registered pursuant to Section 12(b) of the Act:     Title of each class                 Trading Symbol         Name of each exchange on which registered Common stock, par value $0.0001 per share          CCRN              The Nasdaq Stock Market LLC Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 7.01    Regulation FD Disclosure. On February 1, 2024, the Company issued a press release, a copy of which is furnished herewith as Exhibit 99.1. Pursuant to General Instruction B.2 of Current Report on Form 8-K, the information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the